These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 210706)

  • 1. Growth hormone secretion in Addison's disease.
    Crabbé J; Henquin JC; Lambert AE
    Ann Endocrinol (Paris); 1978; 39(2):165-6. PubMed ID: 210706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrin secretion in Addison's disease.
    Vandeput Y; Crabbé J
    Ann Endocrinol (Paris); 1978; 39(2):167-8. PubMed ID: 686660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile and prognosis of Addison's disease in India.
    Agarwal G; Bhatia E; Pandey R; Jain SK
    Natl Med J India; 2001; 14(1):23-5. PubMed ID: 11242694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulins of patients with idiopathic Addison's disease block the in vitro action of adrenocorticotropin.
    Wulffraat NM; Drexhage HA; Bottazzo GF; Wiersinga WM; Jeucken P; Van der Gaag R
    J Clin Endocrinol Metab; 1989 Aug; 69(2):231-8. PubMed ID: 2546959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Addison's disease in children. Etiology and physiopathologic acquisitions].
    Chaussain JL
    Presse Med; 1987 Jan 10-17; 16(1):9-11. PubMed ID: 3027689
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of ACTH on the sleep of normal subjects and patients with Addison's disease.
    Gillin JC; Jacobs LS; Snyder F; Henkin RI
    Neuroendocrinology; 1974; 15(1):21-31. PubMed ID: 4368656
    [No Abstract]   [Full Text] [Related]  

  • 8. [Partial Addison's disease].
    Oki S
    Nihon Rinsho; 2006 May; Suppl 1():578-81. PubMed ID: 16776220
    [No Abstract]   [Full Text] [Related]  

  • 9. Secretion of growth hormone after L-dopa stimulation in patients with renal failure treated with dialyses.
    Kuska J; Kokot F; Sledziński Z
    Acta Med Pol; 1979; 20(3):217-26. PubMed ID: 517160
    [No Abstract]   [Full Text] [Related]  

  • 10. Does recovery of adrenal function occur in patients with autoimmune Addison's disease?
    Smans LC; Zelissen PM
    Clin Endocrinol (Oxf); 2011 Apr; 74(4):434-7. PubMed ID: 21114513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Free fatty acids (FFA) blocking growth hormone secretion induced by L-Dopa].
    Casanueva F; Villanueva L; Peñalva A; Rodríguez R; Vila T; Cabezas-Cerrato J
    Rev Clin Esp; 1979 May; 153(3):217-20. PubMed ID: 482694
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of mineralo-corticoid function in Addison's disease; apropos of 10 cases].
    Schaison G; Sebaoun J; Delzant G; Gilbert-Dreyfus
    Ann Endocrinol (Paris); 1970; 31(4):609-23. PubMed ID: 4322611
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenocorticotropic hormone receptor-blocking immunoglobulins in serum from patients with Addison's disease: a reexamination.
    Wardle CA; Weetman AP; Mitchell R; Peers N; Robertson WR
    J Clin Endocrinol Metab; 1993 Sep; 77(3):750-3. PubMed ID: 8396577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids].
    Casanueva F; Villanueva L; Peñalva A; Barrionuevo JA; Vila T; Cabezas-Cerrato J
    Rev Clin Esp; 1979 May; 153(3):221-4. PubMed ID: 482695
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol enhancement of L-DOPA induced growth hormone stimulation.
    Camanni F; Massara F; Molinatti GM
    Biomedicine; 1974 Jun; 21(6):241-3. PubMed ID: 4441586
    [No Abstract]   [Full Text] [Related]  

  • 16. [State of the cardiovascular system in patients with Addison's disease].
    Viazitskiĭ PO; Sergeev AI
    Kardiologiia; 1970 Jan; 10(1):135-9. PubMed ID: 4314344
    [No Abstract]   [Full Text] [Related]  

  • 17. [Attempt at suppressing the THR-stimulated plasma growth hormone increase with the use of L-dopa in a cromegaly].
    Kasperlik-Zaluska A; Migdalska B; Wiśniewska-Woźniak T; Kaniewski M
    Endokrynol Pol; 1977; 28(1):31-5. PubMed ID: 401736
    [No Abstract]   [Full Text] [Related]  

  • 18. Loperamide modifies but does not block the corticotropin-releasing hormone-induced ACTH response in patients with Addison's disease.
    Ambrosi B; Bochicchio D; Colombo P; Ferrario R; Faglia G
    Horm Metab Res Suppl; 1987; 16():74-5. PubMed ID: 2832297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of endogenous opioids and cortisol on thyrotropin and prolactin secretion in patients with Addison's disease.
    Hangaard J; Andersen M; Grodum E; Koldkjaer O; Hagen C
    J Clin Endocrinol Metab; 1999 May; 84(5):1595-601. PubMed ID: 10323386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid function and growth hormone secretion in amitriptyline-treated depression.
    Leichter SB; Kirstein L; Martin ND
    Am J Psychiatry; 1977 Nov; 134(11):1270-2. PubMed ID: 910982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.